2025-03-14 |
2025-03-14 |
S
Sale
|
Mitchell Micah
Chief Commercial Officer
Officer
|
48,000
-25.5%
5.16
USD 247,565
|
48,000
-25.5%
|
5.16
|
USD 247,565
|
|
2025-03-14 |
2025-03-13 |
B
Purchase
|
KIRK THOMAS F
Non-Executive Director
|
7,400
+3.0%
5.00
USD 37,000
|
7,400
+3.0%
|
5.00
|
USD 37,000
|
|
2025-03-13 |
2025-03-12 |
S
Sale
|
Kovelman Harry
Chief Medical Officer
Officer
|
30,000
-23.4%
5.50
USD 165,018
|
30,000
-23.4%
|
5.50
|
USD 165,018
|
|
2024-09-09 |
2024-09-05 |
S
Sale
|
Kovelman Harry
Chief Medical Officer
Officer
|
6,700
-5.1%
3.76
USD 25,183
|
6,700
-5.1%
|
3.76
|
USD 25,183
|
|
2024-09-05 |
2024-09-03 |
S
Sale
|
Kovelman Harry
Chief Medical Officer
Officer
|
2,029
-1.5%
4.01
USD 8,140
|
2,029
-1.5%
|
4.01
|
USD 8,140
|
|
2024-05-31 |
2024-05-29 |
B
Purchase
|
KIRK THOMAS F
Non-Executive Director
|
50,000
+26.8%
3.50
USD 175,000
|
50,000
+26.8%
|
3.50
|
USD 175,000
|
|
2024-05-17 |
2024-05-15 |
S
Sale
|
Kovelman Harry
Chief Medical Officer
Officer
|
35,426
-26.5%
3.69
USD 130,839
|
35,426
-26.5%
|
3.69
|
USD 130,839
|
|
2024-03-18 |
2024-03-14 |
B
Purchase
|
KIRK THOMAS F
Non-Executive Director
|
50,000
+36.6%
3.50
USD 175,000
|
50,000
+36.6%
|
3.50
|
USD 175,000
|
|
2023-12-08 |
2023-12-08 |
S
Sale
|
Crowley Thomas Aloysius Jr.
Non-Executive Director
|
14,997
0.00
USD 0
|
14,997
|
0.00
|
USD 0
|
|
2023-12-05 |
2023-12-01 |
S
Sale
|
Kovelman Harry
Chief Medical Officer
Officer
|
8,333
0.00
USD 0
|
8,333
|
0.00
|
USD 0
|
|
2023-11-30 |
2023-11-28 |
S
Sale
|
Crowley Thomas Aloysius Jr.
Non-Executive Director
|
14,997
0.00
USD 0
|
14,997
|
0.00
|
USD 0
|
|
2023-12-14 |
2023-11-20 |
B
Purchase
|
KIRK THOMAS F
Non-Executive Director
|
50,000
+57.8%
3.10
USD 155,000
|
50,000
+57.8%
|
3.10
|
USD 155,000
|
|
2023-09-11 |
2023-09-08 |
B
Purchase
|
Morris Milton Mayo
Non-Executive Director
|
15,000
+23.8%
1.06
USD 15,867
|
15,000
+23.8%
|
1.06
|
USD 15,867
|
|
2023-08-31 |
2023-08-30 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
48,400
+5.8%
0.74
USD 36,039
|
48,400
+5.8%
|
0.74
|
USD 36,039
|
|
2023-08-30 |
2023-08-29 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
37,000
+4.7%
0.78
USD 28,797
|
37,000
+4.7%
|
0.78
|
USD 28,797
|
|
2023-08-30 |
2023-08-29 |
B
Purchase
|
Kovelman Harry
Chief Medical Officer
Officer
|
8,333
+5.9%
0.60
USD 5,000
|
8,333
+5.9%
|
0.60
|
USD 5,000
|
|
2023-08-30 |
2023-08-29 |
B
Purchase
|
HENRY DAVID A
Chief Financial Officer
Officer
|
41,666
+13.4%
0.60
USD 25,000
|
41,666
+13.4%
|
0.60
|
USD 25,000
|
|
2023-08-30 |
2023-08-28 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
42,500
+5.7%
0.75
USD 31,794
|
42,500
+5.7%
|
0.75
|
USD 31,794
|
|
2023-01-18 |
2023-01-17 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
307,692
+175.2%
0.33
USD 100,000
|
307,692
+175.2%
|
0.33
|
USD 100,000
|
|
2023-01-18 |
2023-01-17 |
B
Purchase
|
HENRY DAVID A
Chief Financial Officer
Officer
|
76,923
+88.8%
0.33
USD 25,000
|
76,923
+88.8%
|
0.33
|
USD 25,000
|
|
2023-01-18 |
2023-01-17 |
B
Purchase
|
Mitchell Micah
Chief Commerical Officer
Officer
|
15,384
+31.1%
0.33
USD 5,000
|
15,384
+31.1%
|
0.33
|
USD 5,000
|
|
2022-11-22 |
2022-11-22 |
B
Purchase
|
HENRY DAVID A
Chief Financial Officer
Officer
|
9,000
+11.6%
0.55
USD 4,960
|
9,000
+11.6%
|
0.55
|
USD 4,960
|
|
2022-08-08 |
2022-08-05 |
S
Sale
|
Crowley Thomas Aloysius Jr.
Non-Executive Director
|
7,141
-35.6%
1.71
USD 12,218
|
7,141
-35.6%
|
1.71
|
USD 12,218
|
|
2022-03-16 |
2022-03-14 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
5,000
+5.7%
4.22
USD 21,085
|
5,000
+5.7%
|
4.22
|
USD 21,085
|
|
2022-03-11 |
2022-03-11 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
5,000
+6.1%
4.63
USD 23,146
|
5,000
+6.1%
|
4.63
|
USD 23,146
|
|
2021-11-16 |
2021-11-16 |
B
Purchase
|
HENRY DAVID A
Chief Financial Officer
Officer
|
1,000
+2.9%
8.86
USD 8,855
|
1,000
+2.9%
|
8.86
|
USD 8,855
|
|
2021-11-16 |
2021-11-12 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Executive Director
|
1,000
+1.2%
9.86
USD 9,858
|
1,000
+1.2%
|
9.86
|
USD 9,858
|
|
2021-07-22 |
2021-07-21 |
PS
Planned sale
|
Mitchell Micah
Chief Commerical Officer
Officer
|
1,385
0.00
USD 0
|
1,385
|
0.00
|
USD 0
|
|
2021-07-22 |
2021-07-20 |
PS
Planned sale
|
Mitchell Micah
Chief Commerical Officer
Officer
|
5,745
0.00
USD 0
|
5,745
|
0.00
|
USD 0
|
|
2020-02-18 |
2020-02-13 |
B
Purchase
|
KIRK THOMAS F
Non-Executive Director
|
3,500
+75.7%
6.99
USD 24,465
|
3,500
+75.7%
|
6.99
|
USD 24,465
|
|
2020-02-14 |
2020-02-13 |
B
Purchase
|
HENRY DAVID A
Chief Financial Officer
Officer
|
3,500
+525.5%
6.99
USD 24,465
|
3,500
+525.5%
|
6.99
|
USD 24,465
|
|
2020-02-14 |
2020-02-13 |
B
Purchase
|
GUDONIS PAUL R
Chief Executive Officer
Officer
|
6,000
+29.8%
6.99
USD 41,940
|
6,000
+29.8%
|
6.99
|
USD 41,940
|
|
2017-06-13 |
2017-06-09 |
B
Purchase
|
SANGHI STEVE
|
95,238
0.00
USD 0
|
95,238
|
0.00
|
USD 0
|
|
2017-06-13 |
2017-06-09 |
B
Purchase
|
Naft Jonathan
VP, GENERAL MANAGER
|
10,000
0.00
USD 0
|
10,000
|
0.00
|
USD 0
|
|
2017-06-13 |
2017-06-09 |
B
Purchase
|
GUDONIS PAUL R
CHIEF EXECUTIVE OFFICER
Executive Director
|
14,000
0.00
USD 0
|
14,000
|
0.00
|
USD 0
|
|
2017-06-13 |
2017-06-09 |
B
Purchase
|
KIRK THOMAS F
|
20,000
0.00
USD 0
|
20,000
|
0.00
|
USD 0
|
|